Why the study?
Central and peripheral va ECMO are widely used in postcardiotomy cardiogenic shock, but available data regarding their outcomes show controversial results.
Does central venoarterial ECMO compared to peripheral venoarterial ECMO reduce 30-day mortality in patients with postcardiotomy cardiogenic shock?
Population
156 consecutive patients with va ECMO therapy due to PCS
Comparison
Central ECMO vs peripheral ECMO
Design
Retrospective cohort study
Follow-up
30 days
Authors
Loading...
Should not yet alter cannulation choice for expected survival; leaves open the optimal VA-ECMO strategy in postcardiotomy shock.
Does central venoarterial ECMO compared to peripheral venoarterial ECMO reduce 30-day mortality in patients with postcardiotomy cardiogenic shock?
In patients with postcardiotomy cardiogenic shock, central and peripheral venoarterial ECMO have comparable 30-day mortality, but peripheral cannulation is associated with fewer on-site complications and re-explorations.
Djordjevic et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: